MCID: SCH081
MIFTS: 18

Schizophrenia 6

Categories: Mental diseases, Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Schizophrenia 6

MalaCards integrated aliases for Schizophrenia 6:

Name: Schizophrenia 6 57 12 29 73
Sczd6 57 12
Schizophrenia Susceptibility Locus, Chromosome 8p-Related 57
Schizophrenia, Type 6 40

Classifications:



External Ids:

OMIM 57 603013
Disease Ontology 12 DOID:0070082
MedGen 42 C1864275
UMLS 73 C1864275

Summaries for Schizophrenia 6

Disease Ontology : 12 A schizophrenia that has material basis in an autosomal dominant mutation of SCZD6 on chromosome 8p21.

MalaCards based summary : Schizophrenia 6, also known as sczd6, is related to schizophrenia. An important gene associated with Schizophrenia 6 is NRG1 (Neuregulin 1). The drugs Rimonabant and Cannabinoid Receptor Antagonists have been mentioned in the context of this disorder.

Description from OMIM: 603013

Related Diseases for Schizophrenia 6

Diseases in the Schizophrenia family:

Schizophrenia 1 Schizophrenia 3
Schizophrenia 4 Schizophrenia 6
Schizophrenia 5 Schizophrenia 7
Schizophrenia 8 Schizophrenia 2
Schizophrenia 9 Schizophrenia 10
Schizophrenia 11 Schizophrenia 12
Schizophrenia 14 Schizophrenia 13
Schizophrenia 15 Schizophrenia 16
Schizophrenia 18 Schizophrenia 19
Early-Onset Schizophrenia

Diseases related to Schizophrenia 6 via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 schizophrenia 30.3 NRG1 SCZD6

Symptoms & Phenotypes for Schizophrenia 6

Clinical features from OMIM:

603013

Drugs & Therapeutics for Schizophrenia 6

Drugs for Schizophrenia 6 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 6)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rimonabant Approved, Investigational Phase 2 168273-06-1, 158681-13-1 104850
2 Cannabinoid Receptor Antagonists Phase 2
3 Hormone Antagonists Phase 2
4 Hormones Phase 2
5 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
6 Neurotransmitter Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Effects of Rimonabant, on Weight and Metabolic Risk Factors Terminated NCT00547118 Phase 2 Rimonabant;Placebo
2 Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia Not yet recruiting NCT03407950 Not Applicable

Search NIH Clinical Center for Schizophrenia 6

Genetic Tests for Schizophrenia 6

Genetic tests related to Schizophrenia 6:

# Genetic test Affiliating Genes
1 Schizophrenia 6 29 NRG1

Anatomical Context for Schizophrenia 6

Publications for Schizophrenia 6

Variations for Schizophrenia 6

Expression for Schizophrenia 6

Search GEO for disease gene expression data for Schizophrenia 6.

Pathways for Schizophrenia 6

GO Terms for Schizophrenia 6

Sources for Schizophrenia 6

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....